Shares of Biomerica, Inc. (NASDAQ:BMRA – Get Rating) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $3.33 and traded as low as $3.04. Biomerica shares last traded at $3.23, with a volume of 14,631 shares.
Biomerica Trading Up 4.5 %
The firm’s 50 day simple moving average is $3.60 and its two-hundred day simple moving average is $3.33. The firm has a market cap of $43.37 million, a price-to-earnings ratio of -8.07 and a beta of -0.53.
Biomerica (NASDAQ:BMRA – Get Rating) last issued its earnings results on Monday, August 29th. The company reported ($0.14) EPS for the quarter. The firm had revenue of $5.30 million during the quarter. Biomerica had a negative net margin of 26.29% and a negative return on equity of 57.33%.
Hedge Funds Weigh In On Biomerica
Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.
- Get a free copy of the StockNews.com research report on Biomerica (BMRA)
- Is Clothier V.F. Corporation’s 7% Dividend Worth Trying On?
- 3 Reasons Another Shoe May Drop for Skechers
- Bulls Vs Bears: Mullen Automotive Short Interest Grows
- Palantir Falls Into The Hands Of Value Investors
- The Analysts Can’t Keep Up with Arista Networks Stock
Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.